Drug class
Substance P/Neurokinin-1 Receptor Antagonist; Serotonin-3 Receptor Antagonist
Mechanism of action
Neurokinin 1 Antagonists [MoA]
General use cases
- acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy
- acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
